NCT03732027

Brief Summary

The purpose of this study is to compare between two surgical techniques for anterior abdominal wall blocks in obese patients Undergoing Major Gynecological Surgery: Surgical Transversus Abdominis Plane \[TAP\] block versus Rectus Sheath block as regards the efficacy and adverse effects

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable postoperative-pain

Timeline
Completed

Started Oct 2018

Typical duration for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 23, 2018

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

November 3, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 6, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 23, 2020

Completed
Last Updated

August 23, 2021

Status Verified

August 1, 2021

Enrollment Period

1.3 years

First QC Date

November 3, 2018

Last Update Submit

August 19, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total dose of morphine consumption

    First 24 hours postoperatively

Secondary Outcomes (2)

  • Numerical rate scale

    First 24 hours postoperatively

  • Postoperative respiratory functions

    First 24 hours postoperatively

Study Arms (2)

Transversus Abdominis Block [TB] group

ACTIVE COMPARATOR

Patients will receive Surgical Transversus Abdominis Plane Block

Procedure: Surgical Transversus Abdominis Plane Block

Rectus Sheath Block [RB] group

ACTIVE COMPARATOR

Patients will receive Surgical Rectus Sheath Block

Procedure: Surgical Rectus Sheath Block

Interventions

At the end of operation and after hemostasis, 20 ml of 0.25% bupivacaine will be injected intra-abdominally into the Transversus Abdominis plane at the midpoint of the line connecting the crista iliaca and inferior costal margin and at two locations in the lateral abdominal wall at 3-4 cm inferior to the previous midline injection. The same procedure will be repeated on the opposite side using an identical amount of local anesthetic.

Transversus Abdominis Block [TB] group

At the end of operation and after hemostasis,20 ml 0.25% bupivacaine will be administered slowly under direct vision after careful aspiration to the rectus sheath space which is present inbetween rectus abdominis muscle and the posterior layer of its sheath at the upper pole of the midline incision by time of closure of the anterior abdominal wall. The procedure will be repeated on the opposite side.

Rectus Sheath Block [RB] group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • female patients
  • undergoing major gynecological surgery with supraumbilical midline incision the first time
  • Body mass index (BMI) more than 40.

You may not qualify if:

  • patient refusal to participate in the study,
  • reoperation,
  • addiction
  • alcohol abuse
  • hypersensitivity or allergy to the study drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University hospitals

Cairo, 11591, Egypt

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Marwa AK Elbeialy, MD

    Faculty of Medicine,Ain Shams University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesia

Study Record Dates

First Submitted

November 3, 2018

First Posted

November 6, 2018

Study Start

October 23, 2018

Primary Completion

January 23, 2020

Study Completion

January 23, 2020

Last Updated

August 23, 2021

Record last verified: 2021-08

Locations